Female Pattern Hair Loss: Why the Part Widens First

Female pattern hair loss shows up at the part. The scalp line you have drawn in the same place for twenty years starts to read wider in photographs, the ponytail feels thinner in the hand, and the hair near the temples may recede — but there is no bald patch, and often no obvious event to blame it on.

That is the picture the American Academy of Dermatology draws on its page for the condition, last updated 13 December 2022, which also says two things worth holding on to: female pattern hair loss is the most common cause of hair loss in women, and for most women it begins in midlife, in their forties, fifties or sixties.

What is actually happening

Follicles are not dying. They are miniaturising: over successive growth cycles, a follicle produces a finer, shorter, less pigmented hair than it did before, until what grows there barely covers anything. Multiply that across the top of the scalp and the density falls without the hairline retreating the way it classically does in men.

A 2015 review of female pattern hair loss in Current Problems in Dermatology describes the clinical picture as a diffuse thinning over the mid-frontal scalp with a more or less intact frontal hairline, with no inflammation and no scarring, and calls the cause multifactorial — which is the polite academic way of saying that genes, hormones and age all contribute and the proportions differ between women.

The same review makes a point that the marketing never does: it remains unclear which treatments are most effective, and starting early and combining approaches appears to do better than any single one. A field that had a decisive answer would not still be writing sentences like that.

The four things that imitate it

Because the appearance is unspectacular — thinner, not bald — it gets self-diagnosed constantly, and the imitators are treated completely differently. This is the argument for an appointment before a purchase.

Telogen effluvium. A shedding phase triggered by a birth, an illness, a fever, an operation, a sharp weight loss or a new medicine, which arrives as hair coming out in the shower rather than as a widening part. It is usually temporary. If yours followed a birth, the timing of postpartum shedding will tell you more than any product page.

Thyroid disease and deficiencies. A 2019 review of vitamins and minerals in hair loss in Dermatology and Therapy summarises how much of this field is genuinely uncertain, and is equally clear that micronutrients matter to the hair cycle and that deficiency is a modifiable risk factor. The practical version: a blood test your doctor orders is cheap, is decided by a clinician rather than by you, and can find something treatable that no shelf product addresses.

Traction alopecia. Years of tension from tight styles, extensions, weaves or braids pull hair from the follicle, and the loss starts where the tension is — usually the hairline and temples. A 2015 review of ethnic hair disorders places traction alopecia alongside central centrifugal cicatricial alopecia among the conditions dermatologists see most in this context, and the important difference from pattern loss is that early traction alopecia is reversible while the late, scarred stage is not.

Alopecia areata. Patchy, well-defined loss, autoimmune in origin. A 2015 systematic review of its epidemiology puts the lifetime incidence at approximately 2% worldwide, with no sex predominance in the two formal population studies it found. It is not treated with anything sold over the counter.

How a dermatologist tells them apart

The AAD's own description of the appointment is short and worth knowing before you book it, because it tells you what to bring. The dermatologist asks how long the loss has been going on and whether it came on quickly. They look closely at the scalp and nails and any other area losing hair. They do a gentle hair-pull test, which tells them how the hair is growing and whether it breaks. And if they suspect a disease, a deficiency, a hormone problem or an infection, they order a blood test or a scalp biopsy.

What you can usefully bring: roughly when it started, whether it was gradual or sudden, what medicines you started in the preceding six months, any weight change, any cycle change, and — if you have them — photographs of your part taken in the same light a year apart. Nothing in that list costs anything.

What changes the answer

Three things change the treatment conversation more than any product comparison does.

Whether you might become pregnant. This single question rules several options out. The women's minoxidil label says it may be harmful if used when pregnant or breastfeeding. Finasteride is contraindicated in women who are or may become pregnant. The 2023 international PCOS guideline tells clinicians to counsel women taking anti-androgens to use effective contraception. None of that is negotiable by a website.

Whether there is a second symptom. Pattern loss is just hair. Loss with fatigue, weight change, cycle changes, new facial hair or acne is a different conversation, and it belongs with a clinician who can test rather than with a supplement aimed at "hair, skin and nails".

Whether the scalp hurts. Pain, burning, scaling or visible scarring is the signal to be seen quickly rather than to start anything. Scarring alopecias destroy follicles permanently, and time lost there is not recoverable.

What treatment looks like, honestly

Treatment for pattern loss aims to slow the thinning and partly reverse it, and it is ongoing rather than curative. The route with randomised trials in women behind it is topical minoxidil; prescription anti-androgens sit below that with mixed evidence; devices, supplements and cosmetic serums sit below that again on maker-funded or questionnaire evidence. We keep every hair-loss treatment for women graded by what was tested in women on one page, with prices and cautions, precisely so the ordering is not decided by advertising budgets.

One more expectation worth setting: nothing in this field works quickly. The women's 5% minoxidil label says results may occur at three months and tells you to ask a doctor if there is no regrowth by six. Any page promising a visible transformation in a fortnight is selling something other than hair.

Living with it while you decide

Hair loss in women is treated socially as a vanity problem and experienced as something else entirely. The 2023 PCOS guideline — a document written by endocrinologists, not by a wellness brand — explicitly names "the negative psychological impact of female pattern hair loss" as a reason to consider treatment whose evidence is thin. That sentence is in a clinical guideline because clinicians kept seeing what this does to people.

You are allowed to treat it, and allowed not to. What is worth refusing is the pressure to decide immediately, from a page that has not asked you a single question about yourself.